Accessibility Menu
Anteris Technologies Ltd logo

Anteris Technologies Ltd(ASX) AVR

Market CapA$222.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)-82%
5 Year+17%
1 Year-47%
1 Month+3%
A$12.33
-4.05%
-0.52Today
Anteris Technologies Ltd last closing stock price
MetricPriceDate
Last closeAUD 10.542024-12-05
Anteris Technologies Ltd stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+6.46%AUD 9.902024-11-28
1 month+3.33%AUD 10.202024-11-05
3 month+5.51%AUD 9.992024-09-06
Year to date-44.96%AUD 19.152023-12-29
1 year-46.77%AUD 19.802023-12-06
3 year+25.48%AUD 8.402021-12-03
5 year+17.11%AUD 9.002019-12-06
Since inception-81.7%AUD 70.232011-06-27

Anteris Technologies Ltd Financials at a Glance

Market Cap

A$222.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$5.13M

Net Income (TTM)

-$179.02M

EPS (TTM)

A$0.00

P/E Ratio

-2.09

Dividend

A$0.00

Beta (Volatility)

-17.05 (Low)

Price

A$12.33

Volume

2,857

Open

A$12.33

Previous Close

A$12.85

Daily Range

A$12.33 - A$12.33

52-Week Range

A$5.20 - A$23.93

Estimated Earnings Date

Aug 17, 2026

AVR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Anteris Technologies Ltd

Anteris Technologies Ltd is a pioneering company in the structural heart domain, focusing on innovative medical devices. The firm specializes in regenerative tissue technology and is advancing its flagship product, DurAVR™, a 3D single-component aortic valve designed for aortic stenosis treatment.

Products and Services
  • DurAVR™, a 3D single-component aortic valve
  • ADAPT, a product based on regenerative tissue technology
  • Research and development in regenerative medicines
Growth Outlook
  • Recent quarterly revenue increased to AUD 1.29 million
  • Investment in R&D reached AUD 52.78 million in Q4 2025
  • Market potential for aortic valve replacements is expanding rapidly
Financial Highlights
  • Trailing twelve months (TTM) revenue of AUD 5.1 million
  • Net income for Q4 2025 was AUD -73.31 million
  • Cash and cash equivalents stood at AUD 12.58 million as of Q4 2025
Anteris Technologies Ltd operates in the healthcare sector, specifically within the medical devices industry. The company has made significant strides in developing advanced solutions for heart conditions, particularly aortic stenosis. The recent quarterly revenue indicates a growing interest in its products, while substantial investments in research and development highlight the commitment to innovation. Despite facing challenges reflected in net income figures, the company maintains a solid cash position, which may support future growth initiatives. The expanding market for aortic valve replacements presents a promising opportunity for Anteris Technologies Ltd as it continues to innovate and develop its product offerings.
AI Generated • Jul 22, 2026

Industry

Healthcare Equipment and Supplies

Headquarters

Toowong, QLD 4066, AU

AVR Financials

Key Financial Metrics (TTM)

Gross Margin

69.53%

Operating Margin

-5099.87%

Net Income Margin

-5115.59%

Return on Equity

-715.34%

Return on Capital

-4289.36%

Return on Assets

-378.14%

Earnings Yield

-47.85%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$222.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

21.14M

Volume

2.86K

Avg. Volume

28.78K

Financials (TTM)

Gross Profit

$2.78M

Operating Income

-$184.61M

EBITDA

-$178.14M

Operating Cash Flow

-$91.04M

Capital Expenditure

-$4.42M

Free Cash Flow

-$95.47M

Cash & ST Invst.

$12.58M

Total Debt

$2.28M

Anteris Technologies Ltd Performance Analysis

Anteris Technologies Ltd sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-3020.7%
Q42024-12-31-38.6%
Q22025-06-30-69.0%
Q42025-12-31219.8%
Anteris Technologies Ltd sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-19.6%
Q42024-12-3132.0%
Q22025-06-3079.7%
Q42025-12-31-434.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.30M

-26.5%

Gross Profit

$874.00K

+103.7%

Gross Margin

67.49%

N/A

Market Cap

A$222.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$1.28M

N/A

Employees

174

N/A

Net Income

-$73.31M

-97.7%

EBITDA

-$71.87M

-89.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$12.58M

-59.2%

Total Debt

$2.28M

-2.2%

Accounts Receivable

$311.00K

-75.5%

Inventory

$152.00K

-76.5%

Long Term Debt

$1.70M

+25.5%

Short Term Debt

$582.00K

-40.7%

Return on Assets

-3.78%

N/A

Return on Invested Capital

-53.38%

N/A

Free Cash Flow

-$18.92M

+31.6%

Operating Cash Flow

-$18.53M

+29.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ARX.AXAroa Biosurgery Limited
A$0.59+0.85%
MVF.AXMonash IVF Group Limited
A$0.70+0.72%
AVH.AXAVITA Medical, Inc.
A$2.28+0.00%
EMV.AXEMVision Medical Devices Ltd
A$1.73-1.98%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.62+0.07%
ONDSOndas
$8.93-0.09%
SMCISuper Micro Computer
$39.34+0.05%
SPCXSpace Exploration Technologies
$141.98-0.03%

Questions About AVR

What is the current price of Anteris Technologies Ltd?

Anteris Technologies Ltd is trading at A$12.33 per share.

What is the 52-week range for Anteris Technologies Ltd?

Over the past 52 weeks, Anteris Technologies Ltd has traded between A$5.20 and A$23.93.

How much debt does Anteris Technologies Ltd have?

Anteris Technologies Ltd total debt is unavailable.

How much cash does Anteris Technologies Ltd have on hand?

Anteris Technologies Ltd does not have cash on hand data available.

What is Anteris Technologies Ltd’s dividend yield?

Anteris Technologies Ltd does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.